Risk-characterization framework for decision-making at the food and drug administration / Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Year of Publication: | 2011 |
Language: | English |
Online Access: | |
Physical Description: | xiv, 192 p. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Making strategy count in the health and human services sectors : : lessons learned from 20 organizations and chief strategy officers / / Michael Mortell, Tine Hansen-Turton, editors.
Published: ([2013]) -
For the public's health : the role of measurement in action and accountability / / Committee on Public Health Strategies to Improve Health, Board on Population Health and Public Health Practice, Institute of Medicine.
Published: (c2011.) -
Improving health in the United States : the role of health impact assessment / / National Research Council of the National Academies.
Published: (2011.) -
Public health foundations : concepts and practices / / [edited by] Elena Andresen, Erin DeFries Bouldin.
Published: (c2010.) -
Crossing the American health care chasm : : finding the path to bipartisan collaboration in national health care policy / / Donald A. Barr.
by: Barr, Donald A.,
Published: ([2021])